1.
pH-degradable, bisphosphonate-loaded nanogels attenuate liver fibrosis by repolarization of M2-type macrophages.
Proc Natl Acad Sci U S A
; 119(12): e2122310119, 2022 03 22.
Article
En
| MEDLINE | ID: mdl-35290110
2.
End Group Dye-Labeled Polycarbonate Block Copolymers for Micellar (Immuno-)Drug Delivery.
Macromol Rapid Commun
; 43(12): e2200095, 2022 Jun.
Article
En
| MEDLINE | ID: mdl-35339115
3.
Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune Modulators.
J Am Chem Soc
; 143(26): 9872-9883, 2021 07 07.
Article
En
| MEDLINE | ID: mdl-34166595
4.
Monitoring Translation Activity of mRNA-Loaded Nanoparticles in Mice.
Mol Pharm
; 15(9): 3909-3919, 2018 09 04.
Article
En
| MEDLINE | ID: mdl-30028629
5.
Salivary Gluten Degradation and Oral Microbial Profiles in Healthy Individuals and Celiac Disease Patients.
Appl Environ Microbiol
; 83(6)2017 03 15.
Article
En
| MEDLINE | ID: mdl-28087531
6.
Physicochemical and Preclinical Evaluation of Spermine-Derived Surfactant Liposomes for in Vitro and in Vivo siRNA-Delivery to Liver Macrophages.
Mol Pharm
; 13(11): 3636-3647, 2016 11 07.
Article
En
| MEDLINE | ID: mdl-27700112
7.
Reductive Decationizable Block Copolymers for Stimuli-Responsive mRNA Delivery.
Macromol Rapid Commun
; 37(11): 924-33, 2016 Jun.
Article
En
| MEDLINE | ID: mdl-27075781
8.
Antiviral re-treatment of IFN-ribavirin non-responders for recurrent post-transplantation hepatitis C.
Clin Transplant
; 25(1): 131-5, 2011.
Article
En
| MEDLINE | ID: mdl-20438578
9.
Pharmaceutically modified subtilisins withstand acidic conditions and effectively degrade gluten in vivo.
Sci Rep
; 9(1): 7505, 2019 05 16.
Article
En
| MEDLINE | ID: mdl-31097786
10.
SiRNA-mediated in vivo gene knockdown by acid-degradable cationic nanohydrogel particles.
J Control Release
; 248: 10-23, 2017 02 28.
Article
En
| MEDLINE | ID: mdl-27940184
11.
Noninvasive markers of liver fibrosis: on-treatment changes of serum markers predict the outcome of antifibrotic therapy.
Eur J Gastroenterol Hepatol
; 29(3): 289-296, 2017 Mar.
Article
En
| MEDLINE | ID: mdl-27906753
12.
Efficacy and tolerability of pegylated IFN-alpha in patients with neuroendocrine gastroenteropancreatic carcinomas.
J Interferon Cytokine Res
; 26(1): 8-13, 2006 Jan.
Article
En
| MEDLINE | ID: mdl-16426143
13.
Myeloid cells as orchestrators of the tumor microenvironment: novel targets for nanoparticular cancer therapy.
Nanomedicine (Lond)
; 11(20): 2735-2751, 2016 Oct.
Article
En
| MEDLINE | ID: mdl-27658725
14.
Dextran-based therapeutic nanoparticles for hepatic drug delivery.
Nanomedicine (Lond)
; 11(20): 2663-2677, 2016 Oct.
Article
En
| MEDLINE | ID: mdl-27628057
15.
A change of peginterferon may permit continuation of antiviral therapy in hepatitis C virus-infected patients with interstitial pneumonitis.
Liver Int
; 30(10): 1552-4, 2010 Nov.
Article
En
| MEDLINE | ID: mdl-20557455
16.
In Vivo Gene-Silencing in Fibrotic Liver by siRNA-Loaded Cationic Nanohydrogel Particles.
Adv Healthc Mater
; 4(18): 2809-15, 2015 Dec 30.
Article
En
| MEDLINE | ID: mdl-26627192
17.
Identification of Rothia bacteria as gluten-degrading natural colonizers of the upper gastro-intestinal tract.
PLoS One
; 6(9): e24455, 2011.
Article
En
| MEDLINE | ID: mdl-21957450
18.
Discovery of a novel and rich source of gluten-degrading microbial enzymes in the oral cavity.
PLoS One
; 5(10): e13264, 2010 Oct 11.
Article
En
| MEDLINE | ID: mdl-20948997
19.
The epithelial mitogen keratinocyte growth factor binds to collagens via the consensus sequence glycine-proline-hydroxyproline.
J Biol Chem
; 277(30): 26872-8, 2002 Jul 26.
Article
En
| MEDLINE | ID: mdl-11973338